液体活检:对2型糖尿病的游戏改变者
Gratiela Gradisteanu Pircalabioru1,2,3, Madalina Musat1,4,5, Viviana Elian6,7
1eBio-Hub Research-Center, National University of Science and Technology "Politehnica" Bucharest, 6 Iuliu Maniu Bulevard, Campus Building, 061344 Bucharest, Romania.
液体活检为早期2型糖尿病 (T2D) 检测和监测提供了一种最少的侵入性方法. 这种技术使用生物标志物进行分子诊断,有可能彻底改变个性化糖尿病管理.
科学领域:
- 生物标志物 生物标志物
- 分子诊断学 分子诊断
- 糖尿病研究 糖尿病研究
背景情况:
- 全球2型糖尿病 (T2D) 的增加需要创新的诊断工具.
- 液体活检是一种最少的侵入性技术,在瘤学之外显示出有前途.
- 组织活检的局限性推动了对替代诊断方法的兴趣.
研究的目的:
- 审查用于T2D检测和管理的液体活检的最新进展.
- 探索液体活检标记在T2D诊断和并发症监测中的潜力.
- 讨论T2D护理中液体活检的挑战和未来方向.
主要方法:
- 对T2D中液体活检应用的当前文献的综述.
- 分析各种液体活检标记物 (核酸,囊泡,代谢物).
- 讨论诊断和预后影响.
主要成果:
- 液体活检利用无细胞核酸,细胞外囊泡和代谢物进行T2D分子诊断.
- 该技术适用于当组织活检采集是不可行的.
- 新兴研究强调了液体活检在早期检测和监测方面的潜力.
结论:
- 液体活检是T2D管理的有希望的,不那么侵入性的策略.
- 它为早期诊断,预后和个性化治疗监测提供了潜力.
- 克服当前的挑战可以将液体活检确立为糖尿病护理中的改变游戏规则的工具.
更多相关视频
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
08:16Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms
Published on: March 15, 2024
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
